MA45457A - Médicament ophtalmique contenant du salbutamol. - Google Patents

Médicament ophtalmique contenant du salbutamol.

Info

Publication number
MA45457A
MA45457A MA045457A MA45457A MA45457A MA 45457 A MA45457 A MA 45457A MA 045457 A MA045457 A MA 045457A MA 45457 A MA45457 A MA 45457A MA 45457 A MA45457 A MA 45457A
Authority
MA
Morocco
Prior art keywords
product containing
medicinal product
containing salbutamol
ophthalmic medicinal
ophthalmic
Prior art date
Application number
MA045457A
Other languages
English (en)
Inventor
Raouf Rekik
Original Assignee
Raouf Rekik
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Raouf Rekik filed Critical Raouf Rekik
Publication of MA45457A publication Critical patent/MA45457A/fr

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A61K31/585Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin containing lactone rings, e.g. oxandrolone, bufalin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • A61P27/06Antiglaucoma agents or miotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/005Enzyme inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0048Eye, e.g. artificial tears

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
MA045457A 2016-06-27 2017-06-27 Médicament ophtalmique contenant du salbutamol. MA45457A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TN2016000259A TN2016000259A1 (en) 2016-06-27 2016-06-27 Salbutamol (albuterol) eye protective medicament.

Publications (1)

Publication Number Publication Date
MA45457A true MA45457A (fr) 2019-05-01

Family

ID=59416735

Family Applications (1)

Application Number Title Priority Date Filing Date
MA045457A MA45457A (fr) 2016-06-27 2017-06-27 Médicament ophtalmique contenant du salbutamol.

Country Status (7)

Country Link
US (1) US11484513B2 (fr)
EP (1) EP3474836B1 (fr)
JP (1) JP7176960B2 (fr)
CN (1) CN110114066B (fr)
MA (1) MA45457A (fr)
TN (1) TN2016000259A1 (fr)
WO (1) WO2018007864A1 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20250171484A (ko) * 2019-03-02 2025-12-08 인트라바이오 리미티드 질환을 치료하기 위한 류신, 아세틸 류신, 및 관련된 유사체
KR20220018484A (ko) * 2019-06-10 2022-02-15 제니비젼 인크. 시력 장애를 치료하기 위한 방법 및 제형
JP7066293B2 (ja) * 2019-11-12 2022-05-13 株式会社ファンケル サーチュイン1(sirt1)発現増強用組成物
KR20230015433A (ko) * 2020-05-22 2023-01-31 인트라바이오 리미티드 운동실조를 치료하기 위한 아세틸 류신과 4-아미노피리딘 또는 아세타졸아미드의 조합물
CN120916785A (zh) * 2023-04-08 2025-11-07 林颂然 治疗角膜损伤的方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3985897A (en) 1973-12-21 1976-10-12 Mead Johnson & Company Ocular hypotensive process employing dextrorotatory sulfonamidophenethanolamines
SE8701258D0 (sv) * 1987-03-26 1987-03-26 Pharmacia Ab A composition for the topical treatment of glaucoma or ocular hypertension
US5192780A (en) * 1989-12-18 1993-03-09 Alcon Laboratories, Inc. Methods using antiallergics and antihistamines
WO2001041806A1 (fr) 1999-12-07 2001-06-14 Rohto Pharmaceutical Co., Ltd. Compositions ophtalmiques
EP1455795A1 (fr) 2001-12-12 2004-09-15 Pharmacia Corporation Methode de traitement de troubles ophtalmiques a l'aide d'antagonistes epoxy-steroidiens des recepteurs de l'aldosterone
CA2591406A1 (fr) 2004-12-17 2006-06-22 Cipla Limited Composes et compositions pharmaceutiques
WO2010125416A1 (fr) 2009-04-27 2010-11-04 Raouf Rekik Administration de médicaments dans le segment antérieur et le segment postérieur de l'oeil
CA2780453A1 (fr) * 2009-12-02 2011-06-09 Bridge Pharma, Inc. Traitement de la xerophtalmie avec des composes qui augmentent la secretion de la glande de meibomius
TN2010000251A1 (fr) 2010-06-03 2011-11-11 Rekik Raouf N-acetyl-dl-leucine medicament neuro et retino protecteur
TN2010000566A1 (en) 2010-12-03 2012-05-24 Rekik Raouf Folic acid - ramipril combination : cell protective neuroprotective and retinoprotective ophtalmologic drugs
EP2808010A1 (fr) * 2013-05-28 2014-12-03 Sanovel Ilac Sanayi ve Ticaret A.S. Formulation de sirop de salbutamol

Also Published As

Publication number Publication date
CN110114066A (zh) 2019-08-09
CN110114066B (zh) 2023-06-27
TN2016000259A1 (en) 2017-10-06
EP3474836C0 (fr) 2024-01-17
RU2018146575A3 (fr) 2020-09-24
US20190160027A1 (en) 2019-05-30
WO2018007864A1 (fr) 2018-01-11
US11484513B2 (en) 2022-11-01
EP3474836B1 (fr) 2024-01-17
RU2018146575A (ru) 2020-07-28
CA3028924A1 (fr) 2018-01-11
EP3474836A1 (fr) 2019-05-01
JP7176960B2 (ja) 2022-11-22
JP2019524679A (ja) 2019-09-05

Similar Documents

Publication Publication Date Title
EP3435826A4 (fr) Contenant de livraison sécurisé
HUE058677T2 (hu) Meloxicamot tartalmazó gyógyászati készítmény
EP3493799A4 (fr) Composition pharmaceutique decannabis
EP3601085A4 (fr) Contenant inviolable
EP3480211A4 (fr) Conjugué moléculaire contenant du hanp-fc
EP3321207A4 (fr) Capuchon et contenant doté d'un capuchon
EP3493798A4 (fr) Composition pharmaceutique decannabis
MA46334A (fr) Composition pharmaceutique liquide
DK3222550T3 (da) Medicinflaskehætte
PT3500255T (pt) Composições farmacêuticas oftálmicas e utilizações relacionadas com estas
EP3479817A4 (fr) Produit cosmétique.
EP3284693A4 (fr) Contenant et capuchon
EP3452075A4 (fr) Composition pharmaceutique ophtalmique
MA43705A (fr) Formulation pharmaceutique
CL2019000563S1 (es) Envase y dispendio de medicamentos. (divisional solicitud 201800718)
EP3351533A4 (fr) Dérivé biaryle et médicament le contenant
EP3525841A4 (fr) Micro-dispositif d'administration
EP3487482A4 (fr) Nouvelles formules de comprimés de cannabis.
BR112017013012A2 (pt) compostos de indenil, composições farmacêuticas e usos médicos destes
EP3474836C0 (fr) Médicament ophtalmique contenant du salbutamol.
MA44601A (fr) Composition ophtalmique contenant de la pvp-i
EP3434681A4 (fr) Complexe de curcumine-bore et agent pharmaceutique le contenant
MA43978A (fr) Dérivé de sulfonamide hétérocyclique et médicament le contenant
HUE053974T2 (hu) Szemészeti gyógyászati készítmény
EP3524250A4 (fr) Composition pharmaceutique